Related Experiment Videos

Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination

A L Barry1, R N Jones

  • 1Clinical Microbiology Institute, Tualatin, Oregon 97062.

Insights

This study establishes guidelines for in vitro susceptibility testing of cefoperazone and sulbactam. Recommended disk diffusion and dilution methods ensure accurate antimicrobial susceptibility testing for this combination drug.

Area of Science:

  • Microbiology
  • Clinical Pharmacy
  • Antimicrobial Resistance

Background:

  • Cefoperazone, a beta-lactam antibiotic, is often combined with sulbactam, a beta-lactamase inhibitor, to broaden its spectrum of activity.
  • Standardized in vitro susceptibility testing methods are crucial for guiding appropriate antimicrobial therapy.

Purpose of the Study:

  • To define optimal in vitro susceptibility testing methodologies for the combination of cefoperazone and sulbactam.
  • To establish quality control parameters for reliable testing.

Main Methods:

  • Disk diffusion tests using 75/30-microgram disks with existing cefoperazone breakpoints.
  • Broth microdilution tests recommending a 2:1 ratio of cefoperazone to sulbactam.
  • Quality control using established MIC limits for cefoperazone and specific control strains.

Main Results:

  • Disk diffusion zone size limits for gram-negative strains were adjusted by -1 mm compared to cefoperazone alone.
  • Acinetobacter calcoaceticus subsp. anitratus ATCC 43498 was validated as a quality control strain for the sulbactam component.
  • Bacteroides thetaiotaomicron ATCC 29741 was identified as the recommended anaerobic control strain.

Conclusions:

  • The proposed methods provide a reliable framework for in vitro susceptibility testing of cefoperazone-sulbactam.
  • Standardized testing ensures accurate interpretation of results for clinical decision-making.

Related Concept Videos